Our iHP effort this year has been immense, encompassing over 60 individuals and hundreds of meetings. We consulted with experts in pancreatic cancer, dual use, bioinformatics, and many more from May to October this year to ensure our project aligned with patient benefit, patient safety, and sustainable development goals. Additionally, we consulted with pancreatic cancer patients to bridge the gap between research and patients–this effort can be seen on the Patient Consultations page. iGEM McGill's strong commitment to having a project that is both beneficial to the world and safe for the patient is recorded in these meetings and reflects synthetic biology principles of interdisciplinary thinking and responsibility. We are grateful to all the people who gave us advice and support. Without them, PROTEUS would not exist.